LINC01210

Across TCGA pan-cancer cohorts, LINC01210 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01210’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01210 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01210 is over-expressed in tumor.

COAD, STAD, and PRAD are the cancer types where LINC01210 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01210 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.092	.002	6	view →
STAD	All	All	+0.159	.028	3	view →
PRAD	All	All	+0.211	.003	2	view →
LUSC	All	All	+0.058	.032	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC01210–COAD

Open the COAD breakdown →